Active ingredient
- nicotine resinate
Legal Category
GSL: General Sales List
GSL: General Sales List
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL02855/0256.
NiQuitin Mint 2 mg & 4 mg Lozenges
NiQuitin Mint 2 mg and 4mg Lozenges
Nicotine
PATIENT INFORMATION LEAFLET
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
This medicine is available without prescription. However, you still need to use NiQuitin Mint 2mg and 4mg Lozenges carefully to get the best results from them.
IN THIS LEAFLET:
1. What NiQuitin Mint 2mg and 4mg Lozenges are and what they are used for
2. What you need to know before you take NiQuitin Mint 2mg and 4mg Lozenges
3. How to take NiQuitin Mint 2mg and 4mg Lozenges
4. Possible side effects
5. How to store NiQuitin Mint 2mg and 4mg Lozenges
6. Contents of the pack and other information
1. What NiQuitin Mint 2mg and 4mg Lozenges are and what they are used for
NiQuitin Mint 2mg and 4mg Lozenges are used to help people stop smoking. This type of treatment is called Nicotine Replacement Therapy (NRT).
NiQuitin Mint 2mg and 4mg Lozenges can reduce your urge to smoke by providing some of the nicotine previously inhaled from cigarettes and helps you resist cigarettes. NiQuitin Mint 2mg and 4mg Lozenges do not have the health dangers of tobacco because they do not contain the tar or carbon monoxide of cigarette smoke.
This medicine contains:
If possible, when giving up smoking these lozenges should be used with a stop smoking behavioural support programme. For further information talk to your healthcare professional.
2. What you need to know before you take NiQuitin Mint 2mg and 4mg Lozenges
Do not take this medicine if you:
Warnings and precautions
Talk to your doctor or pharmacist or nurse before using NiQuitin Mint 2mg and 4mg Lozenges if you:
Other important information:
When you stop smoking your metabolism slows down and this may alter the way your body responds to certain medicines.
Other medicines and NiQuitin Mint 2mg and 4mg Lozenges
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Children and adolescents
NiQuitin Mint 2mg and 4mg Lozenges is NOT for use in children and adolescents under 12 years of age.
NiQuitin Mint 2mg and 4mg Lozenges with food and drink
Do not eat or drink while a lozenge is in the mouth. Avoid liquids which lower the pH in the mouth such as coffee, juices and soft drinks, for up to 15 minutes before the lozenge is used.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
If you are pregnant or breast-feeding it is best if you can give up smoking without the use of NRT. However, if you have tried and this has not worked, NRT may be recommended by a healthcare professional to help you stop smoking.
Smoking during pregnancy has risks for the baby. These include poor growth before birth, premature birth or stillbirth. Stopping smoking is the best way to improve both your health and that of your baby. The earlier you stop smoking the better.
The decision to use NRT should be made as early on in your pregnancy as possible. Aim to use NRT for only 2 to 3 months.
lf you are breast-feeding tobacco smoke causes breathing difficulties and other problems in babies and children. If you need to use NRT, the amount of nicotine your baby may get is smaller and less harmful than breathing in second-hand smoke. It is better to breastfeed just before you take the product - this helps your baby to get the smallest amount of nicotine possible.
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
There are no known effects of these lozenges on your ability to drive or use machines. However, you should be aware that giving up smoking can cause behavioural changes that could affect you in this way.
NiQuitin Mint 2mg and 4mg Lozenges contains aspartame, mannitol and sodium.
Each lozenge contains about 15 mg of sodium and the maximum daily dose of these lozenges (15 lozenges) contains 225 mg sodium. To be taken into consideration if you are on a controlled sodium diet.
Contains aspartame (E951) which is a source of phenylalanine. May be harmful for people with phenylketonuria.
Mannitol (E421): May cause Laxative effects.
Your lozenges are sugar free.
3. How to take NiQuitin Mint 2mg and 4mg Lozenges
Important: NiQuitin Mint 4mg Lozenges are suitable for smokers who smoke within 30 minutes of waking. NiQuitin Mint 2mg Lozenges are suitable for smokers who have their first cigarette of the day more than 30 minutes after waking up.
Always use Nicotine Lozenges exactly as described in this leaflet. Check with your pharmacist if you are not sure.
The product is for oromucosal use. That means that the nicotine in the lozenge is released slowly into the mouth from where it is absorbed into the body.
In all cases you should use NiQuitin Mint Lozenges by putting one lozenge in your mouth and from time to time move it from one side of your mouth to the other, until it is completely dissolved. This should take around 20-30 minutes. Do not chew the lozenge or swallow it whole. Do not use more than 15 lozenges a day.
If you feel the need to use NiQuitin Mint Lozenges for longer than 6 months in total, you should ask a healthcare professional for advice.
Do not exceed the stated dose. Follow the instructions carefully and do not use more than 15 lozenges in one day (24 hours).
Adults (aged 18 years and over):
The recommended treatment schedule is:
Adults (aged 18 years and over):
The recommended treatment schedule is:
Step 1
Weeks 1 to 6
Initial treatment period
1 lozenge every 1 to 2 hours
Step 2
Weeks 7 to 9
Step down treatment period
1 lozenge every 2 to 4 hours
Step 3
Weeks 10 to 12
Step down treatment period
1 lozenge every 4 to 8 hours
During weeks 1-6 it is recommended that you take at least 9 lozenges per day.
After you have given up you may sometimes feel a sudden craving for a cigarette. You can use a lozenge again if this happens.
Adolescents (aged 12-17 years inclusive):
You should only use NiQuitin Mint Lozenges following advice from a healthcare professional
Children under 12 years of age should not use NiQuitin Mint Lozenges.
Information: You are more likely to quit smoking when using this product with help from your pharmacist, doctor, a trained counsellor, or a support programme.
If you use more NiQuitin Mint 2mg and 4mg Lozenges than you should
If you take more than the recommended number of lozenges per day, you may suffer a nicotine overdose and need to get advice from your doctor. Signs of overdose include headache, sickness, stomach pains and diarrhoea.
In the event that a child has taken any lozenges or if an accidental overdose occurs, contact your doctor or nearest hospital casualty department immediately as this could be fatal. If possible show them the pack or this leaflet.
If you forget to take NiQuitin Mint 2mg and 4mg Lozenges
Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side effects although not everybody gets them. They are similar to those you might get from the nicotine in cigarettes, and are more likely the more nicotine you take.
Stopping smoking itself can cause symptoms such as dizziness, headache, sleep disturbance, cough and cold-like symptoms, depression, irritability, anxiety and night-time awakening.
Stop taking the lozenges immediately and tell a healthcare professional if you get these symptoms:
Uncommon (may affect up to 1 in 100 people):
Very rare (may affect up to 1 in 10,000 people):
Other side effects
Very common may affect more than 1 in 10 people:
Common (may affect up to 1 in 10 people)
Possible side effects continues overleaf.
Uncommon may affect up to 1 in 100 people
If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet.
Reporting of suspected adverse reactions
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store NiQuitin Mint 2mg and 4mg Lozenges
Keep all medicines out of the sight and reach of children.
Do not use this medicine after the expiry date printed on the pack.
Do not store above 25°C and keep in the original carton.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. Contents of the pack and other information
What this medicine contains
The active ingredient is nicotine. Each lozenge contains 2 mg or 4 mg (in the form of a resin complex called nicotine resinate).
The other ingredients are: mannitol (E421), magnesium stearate, sodium alginate, xanthan gum, potassium bicarbonate, sodium carbonate anhydrous, aspartame (E951) and peppermint flavour.
What your medicine looks like and contents of the pack:
Cream / white circular compressed lozenge with an odour of peppermint.
The 2 mg lozenge is embossed with L344 on one side.
The 4 mg lozenge is embossed with L873 on one side.
Your lozenges are available in pack sizes of 36,72, 132, 144 and 204’s. Not all pack sizes may be marketed.
Marketing Authorisation Holder
Manufacturer(s)
The leaflet was revised in: Dec 2019
Omega Pharma Ltd, 1st Floor, 32 Vauxhall Bridge Road, London, SW1V 2SA, UK
+44 (0)203 598 9603
+44 (0)203 598 9603